Skip to content

Clinical trial to study the comparison of two doses of nebulised dexmedetomidine in paediatric patients

comparative study of two doses of nebulised dexmedetomidine for premedication in Paediatric patients: a prospective randomized study

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/042068
Enrollment
80
Registered
2022-04-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Nebulised Dexmedetomidine: Nebulised Dexmedetomidine 2 mcg/kg (two) will be used once for 15 minutes (nebulisation) before general anaesthesia in pediatric patients Control Intervention

Sponsors

gopal krishan jalwal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient of either sex in the age group of 3 to 8 years belong to ASA 1 or II 2. Patient scheduled for elective infraumblical and lower limb surgeries under general anaesthesia with endotracheal intubation

Exclusion criteria

Exclusion criteria: 1. Patient with history of cardiac disease, asthma, seizure disorders, mental retardation, developmental delay, prematurity and allergy will be excluded from the study 2. Surgeries performed under general anaesthesia using supraglottic airway device. 3. Emergency surgeries

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of two doses of nebulised dexmedetomidine as premedication in paediatric patients for parental separation anxietyTimepoint: patient separation anxiety scale will be assessed while shifting the patient to OT time point : 24 weeks

Secondary

MeasureTime frame
1) To compare Mask acceptance score, sedation score, haemodynamic variables, emergence scoresTimepoint: 6 months

Countries

India

Contacts

Public Contactgopal krishan jalwal

AIIMS, Bathinda

gopaljalwal@gmail.com07838939833

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026